These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24332090)

  • 1. Synthesis and biological evaluation of the pirfenidone derivatives as antifibrotic agents.
    Ma Z; Pan Y; Huang W; Yang Y; Wang Z; Li Q; Zhao Y; Zhang X; Shen Z
    Bioorg Med Chem Lett; 2014 Jan; 24(1):220-3. PubMed ID: 24332090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of 8-amino-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives as glycogen synthase kinase-3 (GSK-3) inhibitors.
    Chun K; Park JS; Lee HC; Kim YH; Ye IH; Kim KJ; Ku IW; Noh MY; Cho GW; Kim H; Kim SH; Kim J
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3983-7. PubMed ID: 23683591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of thienopyridinones as Chk1 inhibitors.
    Song P; Peng P; Han M; Cao X; Ma X; Liu T; Zhou Y; Hu Y
    Bioorg Med Chem; 2014 Sep; 22(17):4882-92. PubMed ID: 25042558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylpyrrolidine structural mimics of pirfenidone lacking antifibrotic activity: A new tool for mechanism of action studies.
    Haak AJ; Girtman MA; Ali MF; Carmona EM; Limper AH; Tschumperlin DJ
    Eur J Pharmacol; 2017 Sep; 811():87-92. PubMed ID: 28576410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pirfenidone inhibits p38-mediated generation of procoagulant microparticles by human alveolar epithelial cells.
    Neri T; Lombardi S; Faìta F; Petrini S; Balìa C; Scalise V; Pedrinelli R; Paggiaro P; Celi A
    Pulm Pharmacol Ther; 2016 Aug; 39():1-6. PubMed ID: 27237042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of potent 1,2,4-trisubstituted imidazolinone derivatives with dual p38αMAPK and ERK1/2 inhibitory activity.
    Awadallah FM; Abou-Seri SM; Abdulla MM; Georgey HH
    Eur J Med Chem; 2015 Apr; 94():397-404. PubMed ID: 25778995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azastilbenes: a cut-off to p38 MAPK inhibitors.
    Poon JF; Alao JP; Sunnerhagen P; Dinér P
    Org Biomol Chem; 2013 Jul; 11(27):4526-36. PubMed ID: 23719673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase.
    Selness SR; Devraj RV; Monahan JB; Boehm TL; Walker JK; Devadas B; Durley RC; Kurumbail R; Shieh H; Xing L; Hepperle M; Rucker PV; Jerome KD; Benson AG; Marrufo LD; Madsen HM; Hitchcock J; Owen TJ; Christie L; Promo MA; Hickory BS; Alvira E; Naing W; Blevis-Bal R
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5851-6. PubMed ID: 19751974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking, synthesis and pharmacological activity of novel urea-derivatives designed as p38 MAPK inhibitors.
    de Oliveira Lopes R; Romeiro NC; de Lima CK; Louback da Silva L; de Miranda AL; Nascimento PG; Cunha FQ; Barreiro EJ; Lima LM
    Eur J Med Chem; 2012 Aug; 54():264-71. PubMed ID: 22647219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based de novo design and synthesis of aminothiazole-based p38 MAP kinase inhibitors.
    Park H; Lee S; Hong S
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3784-7. PubMed ID: 26259807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of c-Src kinase inhibitory activity of pyridin-2(1H)-one derivatives.
    Chand K; Prasad S; Tiwari RK; Shirazi AN; Kumar S; Parang K; Sharma SK
    Bioorg Chem; 2014 Apr; 53():75-82. PubMed ID: 24632506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of novel disubstituted dibenzosuberones as highly potent and selective inhibitors of p38 mitogen activated protein kinase.
    Koeberle SC; Fischer S; Schollmeyer D; Schattel V; Grütter C; Rauh D; Laufer SA
    J Med Chem; 2012 Jun; 55(12):5868-77. PubMed ID: 22676210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel 5-(benzyloxy)pyridin-2(1H)-one derivatives as potent c-Met inhibitors.
    Zhang D; Ai J; Liang Z; Zhu W; Peng X; Chen X; Ji Y; Jiang H; Luo C; Geng M; Liu H
    Bioorg Med Chem Lett; 2013 Apr; 23(8):2408-13. PubMed ID: 23474386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38alpha mitogen-activated protein kinase.
    Kim DK; Lim JH; Lee JA; Dewang PM
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4006-10. PubMed ID: 18571921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of N-cyclopropylbenzamide-benzophenone hybrids as novel and selective p38 mitogen activated protein kinase (MAPK) inhibitors.
    Heo J; Shin H; Lee J; Kim T; Inn KS; Kim NJ
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3694-8. PubMed ID: 26115577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of RO3201195 and a pyrazolyl ketone P38 MAPK inhibitor library on the proliferation of Werner syndrome cells.
    Bagley MC; Dwyer JE; Baashen M; Dix MC; Murziani PG; Rokicki MJ; Kipling D; Davis T
    Org Biomol Chem; 2016 Jan; 14(3):947-56. PubMed ID: 26611938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pirfenidone restricts Th2 differentiation in vitro and limits Th2 response in experimental liver fibrosis.
    Navarro-Partida J; Martinez-Rizo AB; Gonzalez-Cuevas J; Arrevillaga-Boni G; Ortiz-Navarrete V; Armendariz-Borunda J
    Eur J Pharmacol; 2012 Mar; 678(1-3):71-7. PubMed ID: 22222821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New aminopyrimidine derivatives as inhibitors of the TAM family.
    Traoré T; Cavagnino A; Saettel N; Radvanyi F; Piguel S; Bernard-Pierrot I; Stoven V; Legraverend M
    Eur J Med Chem; 2013; 70():789-801. PubMed ID: 24239626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
    Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
    Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
    Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
    ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.